Induction of colitis in mice deficient of Peyer's patches and mesenteric lymph nodes is associated with increased disease severity and formation of colonic lymphoid patches

American Journal of Pathology

Volumn 161, Issue 6, 2002, Pages 2273-2282

  Spahn, Thomas W ^a,e   Herbst, Hermann ^a   Rennert, Paul D ^b   Lügering, Norbert ^a   Maaser, Christian ^a   Kraft, Mathias ^a   Fontana, Adriano ^d   Weiner, Howard L ^c   Domschke, Wolfram ^a   Kucharzik, Torsten ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b BIOGEN   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e Department of Medicine B ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; HYBRID PROTEIN; ISOPROTEIN; LYMPHOTOXIN; LYMPHOTOXIN BETA RECEPTOR IMMUNOGLOBULIN FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR 1 IMMUNOGLOBULIN FUSION PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON ULCER; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE DELETION; MESENTERY LYMPH NODE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL;

EID: 0036899330     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64503-8     Document Type: Article

References (42)

1. Spahn T, Weiner HL: The nature of oral gastrointestinal tolerance. Inflammatory Bowel Disease. Edited by J Kirsner Philadelphia, W. B. Saunders Company, 2000, pp 240-250
2. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Buschenfelde KH: Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995, 102:448-455
3. Duchmann R, Schmitt E, Knolle P, Meyer zum Buschenfelde KH, Neurath M: Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur J Immunol 1996, 26:934-938
4. Neutra MR: Current concepts in mucosal immunity. V. Role of M cells in transepithelial transport of antigens and pathogens to the mucosal immune system. Am J Physiol 1998, 274:G785-G791
5. Kawanishi H, Saltzman LE, Strober W: Characteristics and regulatory function of murine con A-induced, cloned T cells obtained from Peyer's patches and spleen: Mechanisms regulating isotype-specific immunoglobulin production by Peyer's patch B cells. J Immunol 1982, 129:475-483
6. Kawanishi H, Saltzman LE, Strober W: Mechanisms regulating IgA class-specific immunoglobulin production in murine gut-associated lymphoid tissues. I. T cells derived from Peyer's patches that switch sIgM B cells to sIgA B cells in vitro. J Exp Med 1983, 157:433-450
7. Yamamoto M, Rennert P, McGhee JR, Kweon MN, Yamamoto S, Dohi T, Otake S, Bluethmann H, Fujihashi K, Kiyono H: Alternate mucosal immune system: Organized Peyer's patches are not required for IgA responses in the gastrointestinal tract. J Immunol 2000, 164:5184-5191
8. Spahn TW, Fontana A, Faria AM, Slavin AJ, Eugster HP, Zhang X, Koni PA, Ruddle NH, Flavell RA, Rennert PD, Weiner HL: Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches. Eur J Immunol 2001, 31:1278-1287
9. Fujihashi K, Dohi T, Rennert PD, Yamamoto M, Koga T, Kiyono H, McGhee JR: Peyer's patches are required for oral tolerance to proteins. Proc Natl Acad Sci USA 2001, 98:3310-3315
10. Spahn TW, Weiner HL, Rennert PD, Lugering N, Fontana A, Domschke W, Kucharzik T: Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches. Eur J Immunol 2002, 32:1109-1113
11. De Togni P, Goellner J, Ruddle NH, Streeter PR, Fick A, Mariathasan S, Smith SC, Carlson R, Shornick LP, Strauss-Schoenberger J, et al: Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994, 264:703-707
12. Banks TA, Rouse BT, Kerley MK, Blair PJ, Godfrey VL, Kuklin NA, Bouley DM, Thomas J, Kanangat S, Mucenski ML: Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J Immunol 1995, 155:1685-1693
13. Koni PA, Sacca R, Lawton P, Browning JL, Ruddle NH, Flavell RA: Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity 1997, 6:491-500
14. Rennert PD, Hochman PS, Flavell RA, Chaplin DD, Jayaraman S, Browning JL, Fu YX: Essential role of lymph nodes in contact hypersensitivity revealed in lymphotoxin-alpha-deficient mice. J Exp Med 2001, 193:1227-1238
15. Rennert PD, James D, Mackay F, Browning JL, Hochman PS: Lymph node genesis is induced by signaling through the lymphotoxin beta receptor. Immunity 1998, 9:71-79
16. Rennert PD, Browning JL, Mebius R, Mackay F, Hochman PS: Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J Exp Med 1996, 184:1999-2006
17. Rennert PD, Browning JL, Hochman PS: Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization. Int Immunol 1997, 9:1627-1639
18. Krawisz JE, Sharon P, Stenson WF: Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984, 87:1344-1350
19. Gomori G: Silver impregnation of reticulum in paraffin sections. Am J Pathol 1937, 13
20. Andres PG, Beck PL, Mizoguchi E, Mizoguchi A, Bhan AK, Dawson T, Kuziel WA, Maeda N, MacDermott RP, Podolsky DK, Reinecker HC: Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: Lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine. J Immunol 2000, 164:6303-6312
21. Dohi T, Fujihashi K, Rennert PD, Iwatani K, Kiyono H, McGhee JR: Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses. J Exp Med 1999, 189:1169-1180
22. O'Leary AD, Sweeney EC: Lymphoglandular complexes of the colon: Structure and distribution. Histopathology 1986, 10:267-283
23. Ishikawa H, Saito H, Suzuki K, Oida T, Kanamori Y: New gut associated lymphoid tissue "cryptopatches" breed murine intestinal intraepithelial T cell precursors. Immunol Res 1999, 20:243-250
24. Suzuki K, Oida T, Hamada H, Hitotsumatsu O, Watanabe M, Hibi T, Yamamoto H, Kubota E, Kaminogawa S, Ishikawa H: Gut cryptopatches: Direct evidence of extrathymic anatomical sites for intestinal T lymphopoiesis. Immunity 2000, 13:691-702
25. Sacca R, Cuff CA, Ruddle NH: Mediators of inflammation. Curr Opin Immunol 1997, 9:851-857
26. Hamada H, Hiroi T, Nishiyama Y, Takahashi H, Masunaga Y, Hachimura S, Kaminogawa S, Takahashi-Iwanaga H, Iwanaga T, Kiyono H, Yamamoto H, Ishikawa H: Identification of multiple isolated lymphoid follicles on the antimesenteric wall of the mouse small intestine. J Immunol 2002, 168:57-64
27. Cebra JJ, Periwal SB, Lee G, Lee F, Shroff KE: Development and maintenance of the gut-associated lymphoid tissue (GALT): The roles of enteric bacteria and viruses. Dev Immunol 1998, 6:13-18
28. Dohi T, Rennert PD, Fujihashi K, Kiyono H, Shirai Y, Kawamura YI, Browning JL, McGhee JR: Elimination of colonic patches with lymphotoxin beta receptor-Ig prevents Th2 cell-type colitis. J Immunol 2001, 167:2781-2790
29. Anjuere F, Martin P, Ferrero I, Fraga ML, del Hoyo GM, Wright N, Ardavin C: Definition of dendritic cell subpopulations present in the spleen, Peyer's patches, lymph nodes, and skin of the mouse. Blood 1999, 93:590-598
30. Iwasaki A, Kelsall BL: Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J Exp Med 1999, 190:229-239
31. Shintani N, Nakajima T, Okamoto T, Kondo T, Nakamura N, Mayumi T: Involvement of CD4+ T cells in the development of dextran sulfate sodium-induced experimental colitis and suppressive effect of IgG on their action. Gen Pharmacol 1998, 31:477-481
32. Fedorak R, Madsen K: Naturally occurring and experimental models of inflammatory bowel disease Inflammatory Bowel Disease. Edited by J Kirsner Philadelphia, J. B. Saunders Company, 2000, pp 113-143
33. Murthy SN, Cooper HS, Shim H, Shah RS, Ibrahim SA, Sedergran DJ: Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci 1993, 38:1722-1734
34. Shintani N, Nakajima T, Nakakubo H, Nagai H, Kagitani Y, Takizawa H, Asakura H: Intravenous immunoglobulin (IVIG) treatment of experimental colitis induced by dextran sulfate sodium in rats. Clin Exp Immunol 1997, 108:340-345
35. Kucharzik T, Lugering A, Lugering N, Rautenberg K, Linnepe M, Cichon C, Reichelt R, Stoll R, Schmidt MA, Domschke W: Characterization of M cell development during indomethacin-induced ileitis in rats. Aliment Pharmacol Ther 2000, 14:247-256
36. Mizoguchi A, Mizoguchi E, Chiba C, Bhan AK: Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice. J Exp Med 1996, 184:707-715
37. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R: A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990, 98:694-702
38. Verdu EF, Bercik P, Cukrowska B, Farre-Castany MA, Bouzourene H, Saraga E, Blum AL, Corthesy-Theulaz I, Tlaskalova-Hogenova H, Michetti P: Oral administration of antigens from intestinal flora anaerobic bacteria reduces the severity of experimental acute colitis in BALB/c mice. Clin Exp Immunol 2000, 120:46-50
39. Neurath MF, Fuss I, Kelsall BL, Presky DH, Waegell W, Strober W: Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med 1996, 183:2605-2616
40. Wolvers DA, Coenen-de Roo CJ, Mebius RE, van der Cammen MJ, Tirion F, Miltenburg AM, Kraal G: Intranasally induced immunological tolerance is determined by characteristics of the draining lymph nodes: Studies with OVA and human cartilage gp-39. J Immunol 1999, 162:1994-1998
41. Mackay F, Browning JL, Lawton P, Shah SA, Comiskey M, Bhan AK, Mizoguchi E, Terhorst C, Simpson SJ: Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis. Gastroenterology 1998, 115:1464-1475
42. Fu YX, Chaplin DD: Development and maturation of secondary lymhoid tissues. Annu Rev Immunol 1999, 17:399-433